Aiken Ozempic Lawsuits

RPWB attorneys are filing lawsuits for Aiken individuals who have experienced gastroparesis, ileus/intestinal blockage and a vision disorder called NAION (non-arteritic anterior ischemic optic neuropathy) as a result of using GLP-1RA drugs. These medications, which include Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound, are often prescribed for diabetes management and weight loss purposes.

Ozempic and other drugs started as diabetes medication but were quickly found to be effective weight loss options. Because of the ease and effectiveness of weight loss through medication, these drugs became very popular very quickly. As the use of Ozempic, Mounjaro, and similar drugs rises in Aiken, South Carolina, negative side effects have been discovered. Many users claim the drugs are causing severe gastrointestinal injuries, including gastroparesis or stomach paralysis. Gastroparesis can be a lifelong digestive disorder, even after stopping the medication. It can be a chronic medication condition where the stomach has a weakened wall, resulting in difficulty transferring food to the small intestine.

Pharmaceutical companies are obligated by law to provide relevant potential drug side effects. Nevertheless, medications such as Ozempic and others of its kind do not include the possibility of gastroparesis, a frequently observed side effect. This lack of disclosure misleads patients and healthcare providers.

If you or a loved one has been impacted by gastroparesis following the use of weight loss medications, then please reach out for a complimentary and confidential case evaluation. You could potentially qualify for substantial compensation. Seek justice for yourself and help enforce the integrity of pharmaceutical marketing to patients and healthcare providers.